ZA200004016B - An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition. - Google Patents
An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition.Info
- Publication number
- ZA200004016B ZA200004016B ZA200004016A ZA200004016A ZA200004016B ZA 200004016 B ZA200004016 B ZA 200004016B ZA 200004016 A ZA200004016 A ZA 200004016A ZA 200004016 A ZA200004016 A ZA 200004016A ZA 200004016 B ZA200004016 B ZA 200004016B
- Authority
- ZA
- South Africa
- Prior art keywords
- iron
- compound
- therapeutical composition
- dextran
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK199800420A DK172860B1 (da) | 1998-03-25 | 1998-03-25 | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200004016B true ZA200004016B (en) | 2001-07-25 |
Family
ID=8093321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200004016A ZA200004016B (en) | 1998-03-25 | 2000-08-07 | An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6291440B1 (fr) |
| EP (1) | EP1066056B2 (fr) |
| JP (1) | JP4558198B2 (fr) |
| KR (1) | KR100612071B1 (fr) |
| CN (1) | CN1147322C (fr) |
| AR (1) | AR015738A1 (fr) |
| AT (1) | ATE220560T1 (fr) |
| AU (1) | AU740432B2 (fr) |
| BR (1) | BRPI9908914B8 (fr) |
| CA (1) | CA2322633C (fr) |
| CZ (1) | CZ300823B6 (fr) |
| DE (1) | DE69902154T3 (fr) |
| DK (2) | DK172860B1 (fr) |
| EA (1) | EA003427B1 (fr) |
| ES (1) | ES2180279T5 (fr) |
| HK (1) | HK1033426A1 (fr) |
| HU (1) | HU228483B1 (fr) |
| ID (1) | ID26778A (fr) |
| NO (1) | NO329591B1 (fr) |
| NZ (1) | NZ505983A (fr) |
| PL (1) | PL195582B1 (fr) |
| PT (1) | PT1066056E (fr) |
| SI (1) | SI1066056T2 (fr) |
| SK (1) | SK284499B6 (fr) |
| TR (1) | TR200002733T2 (fr) |
| UA (1) | UA70939C2 (fr) |
| WO (1) | WO1999048533A1 (fr) |
| ZA (1) | ZA200004016B (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK173138B1 (da) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
| WO2000061191A2 (fr) * | 1999-04-09 | 2000-10-19 | Advanced Magnetics, Inc. | Oxydes de fer colloidaux thermostables recouverts de carbohydrates reduits et des derives de carbohydrates |
| US7871597B2 (en) | 1999-04-09 | 2011-01-18 | Amag Pharmaceuticals, Inc. | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
| KR20020003344A (ko) * | 2001-12-17 | 2002-01-12 | 유형선 | 철분 보급제 경구 투여 제제 조성물 |
| EA006720B1 (ru) * | 2002-04-09 | 2006-04-28 | Фармакосмос Холдинг А/С | Железосодержащие соединения декстрина для лечения железодефицитной анемии |
| DE10249552A1 (de) | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
| US20060116349A1 (en) * | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| DE102004031181A1 (de) * | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | Phosphatadsorbens |
| ITMO20050056A1 (it) | 2005-03-15 | 2006-09-16 | Biofer Spa | Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi. |
| EP1757299A1 (fr) | 2005-08-25 | 2007-02-28 | Vifor (International) Ag | Complexes de fer III pour traiter les manques de fer en patients avec la maladie intestinale inflammatoire |
| KR20080082674A (ko) | 2006-01-06 | 2008-09-11 | 루이트폴드 파머수티컬스, 인코퍼레이티드 | 철을 투여하기 위한 방법 및 조성물 |
| EP1947120A1 (fr) * | 2007-01-19 | 2008-07-23 | Vifor (International) Ag | Liaisons complexes d'hydrate de carbone de fer |
| EP1997833A1 (fr) * | 2007-05-29 | 2008-12-03 | Vifor (International) Ag | Complexes fer-dérivé d'hydrate de carbone hydrosolubles, leur fabrication et médicaments contenants ces complexes |
| CN101585887B (zh) * | 2008-05-22 | 2011-12-14 | 中国科学院过程工程研究所 | 应用纳滤技术对右旋糖酐铁络合物水溶液进行脱盐和浓缩的方法 |
| SI2411053T1 (sl) * | 2009-03-25 | 2017-04-26 | Pharmacosmos Holding A/S | Stabilna spojina železovega oligosaharida |
| CN101967205B (zh) * | 2010-10-12 | 2013-04-17 | 滨州学院 | 一种β-葡聚糖铁复合物及其制备方法 |
| EP2537866A1 (fr) * | 2011-06-21 | 2012-12-26 | Serumwerk Bernburg AG | Dérivés d'amidon hydroxyéthyle, procédé de fabrication de ceux-ci et leurs utilisations thérapeutiques |
| PL398814A1 (pl) | 2012-04-16 | 2013-10-28 | Uniwersytet Jagiellonski | Zastosowanie pochodnych dekstranu do przeciwdzialania lub leczenia niedokrwistosci |
| WO2015198304A1 (fr) | 2014-06-22 | 2015-12-30 | Dexcel Pharma Technologies Ltd. | Compositions pharmaceutiques comprenant du citrate ferrique et procédés de fabrication de celles-ci |
| CA2965722C (fr) * | 2014-10-27 | 2023-02-14 | Pharmacosmos Holding A/S | Traitement ou prevention de l'anemie chez des mammiferes non humains gravides |
| WO2019048674A1 (fr) | 2017-09-11 | 2019-03-14 | Pharmacosmos Holding A/S | Composés complexes de fer à usage thérapeutique |
| CN109646454A (zh) * | 2018-12-29 | 2019-04-19 | 博瑞生物医药（苏州）股份有限公司 | 异麦芽糖酐铁1000的制备方法 |
| CN110183548B (zh) * | 2019-06-28 | 2021-05-18 | 瑞普（天津）生物药业有限公司 | 一种低分子葡聚糖铁的制备方法及其应用 |
| WO2023012242A1 (fr) | 2021-08-03 | 2023-02-09 | Pharmacosmos Holding A/S | Composés de complexe de fer pour une utilisation sous-cutanée dans la thérapie de la carence en fer chez les animaux de compagnie |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK117730A (fr) | ||||
| USRE24642E (en) | 1959-04-28 | Therapeutic preparations of iron | ||
| US2885393A (en) | 1956-02-24 | 1959-05-05 | R K Laros Company | Dextran-iron complex and process for making same |
| US3093545A (en) | 1960-08-29 | 1963-06-11 | Armour Pharma | Therapeutic iron-dextran preparations |
| US3234209A (en) * | 1963-09-13 | 1966-02-08 | Chemicals Inc | Process for making iron hydrogenated dextran |
| DE1293144B (de) * | 1964-11-04 | 1969-04-24 | Hausmann Ag Labor | Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid |
| GB1183940A (en) | 1966-10-22 | 1970-03-11 | Fisons Pharmaceuticals Ltd | Ferric Hydroxide Complexes |
| GB1200902A (en) | 1967-05-13 | 1970-08-05 | Fisons Pharmaceuticals Ltd | Iron-dextran complexes |
| CH507993A (de) | 1967-07-13 | 1971-05-31 | Kutnowskie Zakl Farma | Verfahren zur Herstellung von Eisen(III)-komplexverbindungen mit hydriertem Dextran |
| DK129353B (da) | 1968-04-29 | 1974-09-30 | Fisons Pharmaceuticals Ltd | Analogifremgangsmåde til fremstilling af et ferrihydroxid-dextranderivatkompleks eller en opløsning deraf. |
| US3697502A (en) | 1969-11-03 | 1972-10-10 | Christensen Henry M | Method of making iron dextran-preparations |
| GB1562913A (en) * | 1976-06-16 | 1980-03-19 | Fisons Ltd | Fractionating fluid mixtures of dextrans |
| DE3422249A1 (de) * | 1984-06-15 | 1985-12-19 | Pfeifer & Langen, 5000 Köln | Wasserloesliches eisendextran und verfahren zu seiner herstellung |
| US4827945A (en) | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
| US5102652A (en) * | 1986-07-03 | 1992-04-07 | Advanced Magnetics Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
| IT1263831B (it) * | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
| RU2093577C1 (ru) * | 1993-11-04 | 1997-10-20 | Государственный институт кровезаменителей и медицинских препаратов | Способ получения декстрана |
| GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
| US5624668A (en) * | 1995-09-29 | 1997-04-29 | Luitpold Pharmaceuticals, Inc. | Iron dextran formulations |
-
1998
- 1998-03-25 DK DK199800420A patent/DK172860B1/da not_active IP Right Cessation
-
1999
- 1999-03-24 JP JP2000537579A patent/JP4558198B2/ja not_active Expired - Lifetime
- 1999-03-24 DK DK99908785T patent/DK1066056T4/da active
- 1999-03-24 PL PL99343164A patent/PL195582B1/pl unknown
- 1999-03-24 AR ARP990101309A patent/AR015738A1/es active IP Right Grant
- 1999-03-24 AT AT99908785T patent/ATE220560T1/de active
- 1999-03-24 CN CNB998042498A patent/CN1147322C/zh not_active Expired - Lifetime
- 1999-03-24 TR TR2000/02733T patent/TR200002733T2/xx unknown
- 1999-03-24 US US09/509,454 patent/US6291440B1/en not_active Expired - Lifetime
- 1999-03-24 EA EA200000981A patent/EA003427B1/ru not_active IP Right Cessation
- 1999-03-24 ID IDW20001881A patent/ID26778A/id unknown
- 1999-03-24 AU AU28273/99A patent/AU740432B2/en not_active Ceased
- 1999-03-24 DE DE69902154T patent/DE69902154T3/de not_active Expired - Lifetime
- 1999-03-24 NZ NZ505983A patent/NZ505983A/xx not_active IP Right Cessation
- 1999-03-24 HU HU0101189A patent/HU228483B1/hu unknown
- 1999-03-24 ES ES99908785T patent/ES2180279T5/es not_active Expired - Lifetime
- 1999-03-24 CA CA002322633A patent/CA2322633C/fr not_active Expired - Fee Related
- 1999-03-24 CZ CZ20003535A patent/CZ300823B6/cs not_active IP Right Cessation
- 1999-03-24 BR BRPI9908914 patent/BRPI9908914B8/pt not_active IP Right Cessation
- 1999-03-24 PT PT99908785T patent/PT1066056E/pt unknown
- 1999-03-24 KR KR1020007010563A patent/KR100612071B1/ko not_active IP Right Cessation
- 1999-03-24 SI SI9930103T patent/SI1066056T2/sl unknown
- 1999-03-24 UA UA2000095459A patent/UA70939C2/uk unknown
- 1999-03-24 WO PCT/DK1999/000160 patent/WO1999048533A1/fr active IP Right Grant
- 1999-03-24 SK SK1409-2000A patent/SK284499B6/sk not_active IP Right Cessation
- 1999-03-24 EP EP99908785A patent/EP1066056B2/fr not_active Expired - Lifetime
-
2000
- 2000-08-07 ZA ZA200004016A patent/ZA200004016B/xx unknown
- 2000-08-18 NO NO20004151A patent/NO329591B1/no not_active IP Right Cessation
-
2001
- 2001-06-13 HK HK01104034A patent/HK1033426A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200004016B (en) | An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition. | |
| CA2376596A1 (fr) | Anticorps anti-erbb2 humanises et traitement a l'aide de ces anticorps | |
| CA2140106A1 (fr) | Methode de traitement des affections vasculaires hyperproliferatives | |
| CA2195213A1 (fr) | Utilisation du droloxifene pour le traitement des affections cardio-vasculaires | |
| CA2344166A1 (fr) | Compositions de .beta.-glucanes et d'immunoglobulines specifiques | |
| PT2322187E (pt) | Utilização de uridina em combinação com colina para o tratamento de disfunções de memória | |
| EP1074566A4 (fr) | Copolymere, son procede de preparation et composition de produit de reserve | |
| EP1576956A3 (fr) | Traitement chromé/biotiné du diabète type ii | |
| WO2000074662A3 (fr) | Traitement de l'arthrite | |
| HK1062170A1 (en) | Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds | |
| CA2001765A1 (fr) | Chelants possedant une fonctionnalite d'ortho-ligature et ses complexes | |
| MX198647B (es) | La preparacion de oligoaminas y poliaminas. | |
| HUP0100974A3 (en) | Integrated additive composition, process for its preparation and its use | |
| WO1999011256A8 (fr) | L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme | |
| EP0672736A3 (fr) | Compositions de revêtement, leur procédé de préparation et leur utilisation. | |
| PL345204A1 (en) | Compounds with growth hormone releasing properties | |
| WO2003047697A3 (fr) | Methodes de traitement du cancer utilisant un inhibiteur de farnesyl transferase (fpt) et des agents antineoplasiques | |
| GB9917346D0 (en) | Medicament for treating premature ejaculation | |
| WO2000069841A3 (fr) | Benzofuranylaminoalcools | |
| CA2269031A1 (fr) | Traitement de l'incontinence d'urine et compositions a cet usage | |
| CA2368370A1 (fr) | Utilisation de dienogest en dose elevee | |
| AU7078298A (en) | Method for the diagnosis, treatment and prophylaxis of premature ejaculation andcatheter for the diagnosis, treatment and prophylaxis of premature ejaculation | |
| ZA955514B (en) | Process for the preparation of 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones | |
| EP1176137A4 (fr) | Complexe de fer poudreux de s,s-ethylenediamine-n,n'-acide disuccinique et son procede de production | |
| CA2360311A1 (fr) | Solutions de dialyse et methodes de dialyse ameliorees |